This study deals with the isolation and quantitative estimation of urinary ketosteroids following the administration of adrenocorticotrophic hormone (ACTH) and cortisone acetate to two normal young men, with appropriate control studies of their endogenous steroid excretion. The study was undertaken to obtain information on several aspects of endocrine physiology. The first of these was to provide an acceptable comparison for an investigation of the influence of stress upon the young male subject as measured by the output of steroid hormone metabolites. The second was to secure basic information relating to the nature of the adrenal response and the metabolic pathways utilized when the adrenal gland was stimulated by its trophic hormone as well as when the pituitary secretion was suppressed by the administration of large doses of exogenous steroid. The third was to obtain data after intravenously administered ACTH for comparison with the several studies in which much larger amounts of this hormone were administered by the intramuscular route. The fourth was to obtain evidence from related metabolic experiments on single individuals, serving as their own controls, to test the several generalizations that have been made concerning the metabolic fate of steroid hormones. While the design of the studies and the methods employed provide information upon these topics, it should be emphasized that in certain respects the amount of hormone administered has been in the pharmacologic range and the end products studied constitute only a portion of the total metabolites. 1 This investigation was carried out under contract DA-49-007 MD-341 with the Office of the Surgeon General, Department of the Army. 2 Research Fellow of the American Cancer Society upon recommendation of the Committee on Growth of the National Research Council. t Konrad Dobriner died March 10, 1952 . EXPERIMENTAL The two subjects studied were hospitalized on the Metabolic Unit of the Peter Bent Brigham Hospital during both experimental periods. Both subjects were 21 years of age. The details of the studies were as follows.
Subject C21. Following a nine-day control period (Period 1) a daily intravenous infusion of 20 mg. of ACTH (Armour) dissolved in 500 ml. of 5 per cent dextrose in water was administered. These infusions continued for a total of 3 consecutive three-day periods (Periods 2, 3, and 4). The duration of each infusion was 8 hours. Except for 2.7 gm. of KCl per day, no other medication was given. Blood pressure and body weight remained essentially constant during the experimental period. Twenty days following the last day of ACTH administration, he was re-admitted to the Metabolic Unit for a six-day control period (Period 5). Then 500 mg. per day of cortisone acetate (Merck) was administered orally, in divided dosage, for 2 consecutive three-day periods (Periods 6 and 7). An inadvertent omission of one dose (125 mg.) of cortisone acetate on the fifth day (Period 7) was compensated by increasing the dose to 625 mg. on the sixth and last day of this experimental period. He received 2.7 gm. per day of KCl during the period of cortisone administration. Blood pressure and body weight did not change during this portion of the study. Subject M21. The same lot of ACTH was administered, and essentially the same program was followed with this subject, as with subject C21. However, urines from only eight days of the ACTH administration period were studied in M21. A small weight gain was recorded at the end of this period. Blood pressure did not change. Sixteen days after the end of the ACTH experiment, he was re-admitted for the cortisone study. Details of this experiment were similar to those in the study on subject C21. Blood pressure did not change at the end of cortisone administration, but again a slight weight gain was recorded.
Control urines were pooled. Urine collected during the period of ACTH and cortisone administration were combined into consecutive three-day pools (except for the two-day ACTH pool (Period 4) in the study on subject M21). The urinary steroid conjugates were hydrolyzed by a combination of methods employing enzymatic (beef liver 8-glucuronidase), mild and vigorous acid hydrolysis (see Method D [1] ). The neutral obtained and the residual urine after incubation with the enzyme followed by ether extraction.
steroid extract obtained after enzymatic hydrolysis was partitioned between benzene and water according to the method of Mason (2) . The benzene soluble fraction was then combined with the neutral steroid extract from the acid hydrolysis. The combined extract was then separated into "ketonic" and "non-ketonic" fractions and the ketonic portion was further separated into "a" and ",8" ketosteroids (3). "Formaldehydogenic" steroids, using the method of Hollander, Di Mauro, and Pearson (4), as well as ketosteroids, by the method of Talbot, Butler, MacLachlan, and Jones (5), were measured on appropriate fractions. These values are recorded in Table I for Subject C and Table II for Subject M.
Only the "a-ketosteroids" (line G, Tables I and II) were employed for the isolation of the individual steroids. Separation of the ketosteroids was achieved by adsorption chromatography on silica gel and the components were identified by infrared spectrometry. The separation of urinary ketosteroid metabolites by adsorption chromatography on silica gel, although extensively used in the past in these laboratories, has not hitherto been described. The general procedure used was, in all respects, very similar to that employed for chromatography with alumina as the adsorbent except for the sequence of solvents used for elution. The ratio of adsorbent to ketosteroid (in terms of dehydroisoandrosterone as standard) was customarily 500: 1. The material to be chromatographed was placed upon the previously prepared column in as small a volume as practical of a mixture of petroleum ether and approximately 0.5 per cent ethyl acetate. The column was then developed with small increments of ethyl acetate in petroleum ether. The acetates of androsterone and etiocholanolone were usually eluted with petroleum ether: ethyl acetate 93: 7. Androstane-3,17-dione and etiocholane-3,17-dione were usually eluted with the same mix- 
RESULTS
Quantitative values for isolated ketosteroids during both experimental periods for C21, are listed in Table III and for M21, in Table IV .
Subject C21
The control values for each of the individual compounds studied were typical of those observed in healthy young males (1) . The sum of the C19, 11 -desoxysteroids promptly increased, during the first period of ACTH administration. Then, despite the continued administration of ACTH, these compounds remained at essentially constant, though increased levels. Both etiocholanolone and androsterone were augmented, the latter somewhat more than the former. The increase in levels of C19 11-oxygenated steroids was relatively of greater magnitude than that of the C19 11desoxy compounds. This appears to be part of 156y1 ATTALLAH XAPPAS, XONRAD DOBRINER, ANID T. V. GALLAGHER the normal characteristic pattern of adrenal response to ACTH (6) . All components of this group of steroids, 3a-hydroxyetiocholane-11,17dione, 3a,l lp-dihydroxyandrostane-17-one, and 3a,11,8-dihydroxyetiocholane-17-one shared initially in this increase, but during the later periods, the C19 11-hydroxylated compounds predominated. Steroid levels during the second control period were, as expected (7) , essentially the same as during the first control. During cortisone administration, the C19 11-desoxysteroids decreased in stepwise fashion, with etiocholanolone decreasing somewhat less than androsterone. As expected, levels of C19 11-oxygenated steroids increased markedly with 3c-hydroxyetiocholane-11, 17-dione predominant. Small increases in 3a,1 1,8dihydroxyetiocholane-17-one, and still smaller but distinct increases of 3a,1 1ft-dihydroxyandrostane-17-one were found.
Subject M21
Essentially similar metabolic results were observed in this subject. Under ACTH stimulation, levels of both 1 1-oxygenated and 1 1-desoxysteroids increased; the former, as expected, to a relatively greater extent. The increase in 11-desoxysteroids in this subject, was not as pronounced, nor as sustained as that in C21 and androsterone excretion was not measurably increased. The qualitative and quantitative pattern of C19, 11-oxygenated steroids was essentially similar to that observed in C21. Both etiocholanolone and androsterone decreased during cortisone administration. The increase in C19 11-oxygenated steroids during cortisone administration was similar but not as pronounced as that observed in C21.
DISCUSSION
The consistent rise in output of 11-desoxy-17ketosteroids following the administration of ACTH to these and other (6) normal men was the most striking, though perhaps not unexpected, alteration in urinary ketosteroids observed. Although the two compounds, androsterone and etiocholanolone, represent the major metabolites of testosterone in man (8) (9) (10) , the fact that they are consistently present in the urine of normal women (8) , are identified in the urine of castrate males and females (11) , and are excreted in large amounts in frank adrenal disease (12) indicates the existence of an adrenocortical precursor as well. While the absolute amounts of these two substances increased, the ratio of one to the other throughout the interval of stimulation by ACTH remained essentially unaltered (Tables III and  IV) . This relatively constant ratio was maintained during the period of cortisone administration with the exception of the last period in C21. This finding indicates that exogenous cortisone equally suppressed the production of the precursors of both metabolites. A simple and not unreasonable interpretation would be that the maintenance of a constant ratio during cortisone administration reflected suppression of a single precursor of both compounds. It is likely that this precursor was of adrenal origin, although depression of some testicular or pituitary hormone by the large dose of cortisone cannot be excluded. Since both androstane and etiocholane isomers were increased during ACTH administration it would be reasonable to assume that a C19 steroid such as testosterone, A4-androstene-3,17-dione or dehydroisoandrosterone was secreted by the adrenal gland. The magnitude of the increase or decrease of the 11-desoxy metabolites is consistent with this view, since each of these potential precursors is converted to both urinary 17-ketosteroids. The amount of hormone secreted (or suppressed) would approximate twice the increment (or decrement) found as metabolites in the urine (10) on the presumption that testosterone was the precursor. The conversion of C21 17-hydroxy precursors, such as 17a-hydroxyprogesterone or Reichstein's "Substance S" to 17-ketosteroids is an inefficient biochemical process as evidenced by the small yield of C19D 17-ketosteroids (13, 14) ; the same is true for cortisone, exemplified in the present studies, as well as in others in which both isotopic and unlabelled precursors were employed (15) (16) (17) . It seems logical, therefore, to defer consideration of a C21 steroid as a potential precursor and to focus attention upon more proximate C1, steroids which could normally be present in the internal secretions from the adrenal gland and would be increased under intense stimulation by ACTH.
The choice of a single compound from the more likely C19 precursors mentioned is difficult but there is indirect evidence that points to a plausible selection. It is clear that in certain conditions such as adrenal hyperplasia of the virilizing type and in less frank manifestations of adrenal hypersecretion such as excessive hirsutism in women (18, 19) the adrenal gland can produce a physiologically active androgen. This is apparent not only from the overt manifestations seen in the several clinical states but is evident from the finding of elevated quantities of the metabolites of androgens (e.g., androsterone and etiocholanolone) in the urine. Of the three compounds under discussion, testosterone and .A4-androstene-3,17-dione are the more effective in this respect. Moreover, while these two compounds can be readily metabolized to androsterone and etiocholanolone by man, they are not transformed to dehydroisoandrosterone (9, 20, 21) . Since the "/3" ketosteroid fractions from the urine of these two subjects showed only minor increases during ACTH administration, and since the excretion of dehydroisoandrosterone can be so greatly increased in abnormal adrenal hyperactivity (12) , it would seem unlikely that dehydroisoandrosterone was, under physiologic circumstances, the major adrenal precursor of these two metabolites. As between testosterone and A4-androstene-3,17-dione, the evidence favors the latter since this compound has been isolated from beef adrenal extracts by von Euw and Reichstein (22) and evidence for its presence in cow adrenal perfusates has been adduced by Bloch, Dorfman, and Pincus (23) . Very recently Bloch, Benirschke, and Dorfman (24) have obtained evidence for the presence of this compound in a human fetal adrenal and the adrenal of a newborn male pseudohermaphrodite. At present there is insufficient evidence available on the adrenal hormones in man to make a definitive statement about the chemical nature of the androgen which serves as the precursor of the metabolites androsterone and etiocholanolone. It is clearly necessary to study the 1 1-desoxysteroids from the human adrenal and we have initiated studies of this problem. As a working hypothesis, however, the suggestion can be advanced that either A4-androstene-3,17dione or testosterone would account well for the findings demonstrated in this investigation.
Following the administration of cortisone the urinary C19 1 1-oxygenated ketosteroids have been studied in detail (15) and the results in subject C21 and M21 confirm the general conclusions drawn from these previous data. In particular, it is evident that 3a,11,f8-dihydroxyandrostane-17one is a metabolite, though in small amount, of cortisone, and presumably hydrocortisone. It is clear from previous work that the 11-keto and 11,1/-hydroxy functional groups are metabolically interconvertible; the degree and direction of this oxidation-reduction may reflect a variety of factors, the significance of which remains for further clarification. Thus in the subject studied by Burstein, Savard, and Dorfman (15) , the major C1, 17-ketosteroid metabolite of cortisone was 3a,11,8dihydroxyetiocholane-17-one, while in our two subjects, the major 17-ketosteroid metabolite was 3a-hydroxyetiocholane-11,17-dione. The predominant conversion of adrenosterone to 3a,11,8-dihydroxyandrostane-17-one (25) , rather than to the 1 1-keto analog, poses similar problems of interpretation.
Dorfman (26) has reached the tentative conclusion that 3a,11,8-dihydroxyandrostane-17-one in the urine reflects, to a considerable extent, the metabolic transformation of a C19 11-oxygenated precursor. Thus, this metabolite could arise from a C21 adrenal hormone such as hydrocortisone by a metabolic alteration that removed the two carbon side-chain prior to any change in the a,,8 unsaturated ketone system in Ring A or directly from a C19 precursor such as adrenosterone or 1 1f-hydroxy-A4-androstene-3,17-dione. Since the latter two products are undoubtedly secreted by the adrenal gland but do not serve the vital functions of hydrocortisone, their metabolites may reflect only indirectly the extent of the adrenal response to stress. With these possibilities in view, it may be more significant to direct attention to the individual ketosteroids rather than to consider all these metabolites as a group. A more accurate indication of "adrenal response" with respect to metabolically active steroids of the hydrocortisone type would be the urinary levels of "non-ketonic" C21 products of hormone metabolism such as pregnane-3a,11,8,17a,20a,21-pentol and related isomers (27) since these compounds account for a higher proportion of the total metabolites than do the C19 ketosteroids.
The increase in levels of 3a,1 1,8-dihydroxyandrostane-17-one and 3a,11,8-dihydroxyetiocholane-17-one during the administration of ACTH approached the increase in these compounds following cortisone administration. After an initial increase, the levels of 3a-hydroxyetiocholane-11,17-dione during ACTH administration decreased steadily to control values. The concurrent increase in levels of other 11-oxygenated metabolites makes it unlikely that this represents technical error or loss. A similar response was noted in a subject treated with ACTH intramuscularly (6) . The results in these subjects therefore parallel those reported earlier. A point of difference from the earlier studies of the effect of ACTH in young men is found in the relatively minor increase in the ",8" ketosteroids of the two subjects of the present investigation. Whereas one of the previous subjects showed an increase in ",8" ketosteroids to a level of 13 mg. per day at the peak value, no such relative or absolute change was apparent with these two men. In our experience, the alterations in the ",8" fraction may be erratic and the changes observed cannot always be correlated with physiological or biochemical processes. In general terms, however, the present study agrees well with the prior report, when consideration is given to the several methodological changes as well as the different route of ACTH administration. In addition it may be noted that the quality of the ACTH available for the present study was probably superior to that used in the earlier investigations.
A rough comparison of the dose-response relationships after ACTH and cortisone acetate administration can be made from these, and previous data (6) . From the increase in excretion of C19 11-oxygenated metabolites during the two experimental periods, 20 mg. of ACTH administered as in this study is approximately equal to 150 to 250 mg. of cortisone acetate orally. On the same basis 20 mg. of ACTH intravenously administered produced about the same response as 100 mg. of ACTH administered by the intramuscular route. Quantitative relationships of this nature are approximations, however, since the limitations of these comparisons are evident. Alterations in the rate of absorption of administered hormones from the intramuscular depot or the gastrointestinal tract, variations in the degree of hormonal alteration and the unknown influences of biologic variations in experimental subjects may seriously influence not only quantitative relation-ships, but also qualitative patterns of metabolism as well. SUMMARY The qualitative and quantitative pattern of ketosteroid response has been studied in two normal young men treated experimentally with large doses of oral cortisone acetate and intravenous ACTH. Conclusions have been drawn concerning the metabolic pathways utilized when large doses of adrenal hormones are provided from exogenous, as compared with endogenous sources. In the latter situation the ketosteroid response indicates the existence of a C19 11-desoxy substance of adrenal origin. This hormonal substance, we conclude from a consideration of available data may represent adrenocortical production of testosterone or a chemically closely related compound and the metabolites may thus be a measure of the primary adrenal androgen.
